![Gordon W. Laurie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Gordon W. Laurie
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TearSolutions, Inc.
![]() TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Oprichter | 01-01-2013 | - |
Corporate Officer/Principal | 01-01-2013 | - |
Loopbaan van Gordon W. Laurie
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
TearSolutions, Inc.
![]() TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Health Technology |
- Beurs
- Insiders
- Gordon W. Laurie
- Ervaring